| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 1,000 | 500 | 500 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INVESTMENT - MS 4921 | 1,250,033 | 1,669,846 |
| INVESTMENT - UBS 6772 | 420,976 | 177,690 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESTMENT IN APPLIED STEMCELL INC | AT COST | 52,500 | 52,500 |
| INVESTMENT IN NEXBIO | AT COST | 571,170 | 571,170 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA LLC | -32,295 | -90,030 | -90,030 |
| 7 HILLS PHARMA LLC - CONVERTIBLE NOTE | 101,424 | 101,425 | 101,425 |
| INVESTMENT IN 4J THERAPEUTICS INC | 0 | 200,000 | 200,000 |
| Description | Amount |
|---|---|
| MISCELLANEOUS | 226 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK CHARGES | 52 | 52 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| INVESTMENT IN 7 HILLS PHARMA, LLC | -57,728 | -57,728 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INVESTMENT FEES | 19,686 | 19,686 | 0 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FOREIGN TAXES | 251 | 251 | 0 | |
| FEDERAL TAXES | 6,070 | 0 | 0 |